Stationary Ultrasonic Diathermy Devices
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Policy on coverage and medical necessity for stationary (wearable/home) ultrasonic diathermy devices for treatment of musculoskeletal pain for Blue Cross Blue Shield - Rhode Island members, applying to Medicare Advantage and commercial products.
No material clinical or coverage changes in this revision.
Coverage criteria and medical necessity
Coverage stance
Applies to Medicare Advantage Plans per policy.
Applies to Commercial Products per policy.
Individuals with implanted metal devices, including pacemakers, prostheses, and intrauterine devices, are at risk of serious injury if they undergo diathermy. Patients with certain medical conditions (for example, cancer) may also be inappropriate candidates for ultrasonic diathermy and should be evaluated carefully before treatment.
Providers should confirm the presence or absence of implanted metal devices and relevant comorbid conditions during clinical assessment and document contraindications prior to considering ultrasonic diathermy.
For Commercial Products, stationary ultrasonic diathermy devices for the treatment of musculoskeletal pain are considered not medically necessary because the evidence is insufficient to determine the effects of the technology on health outcomes.
Claims submitted using HCPCS codes K1004 (low frequency ultrasonic diathermy treatment device for home use) or K1036 (supplies and accessories for low frequency ultrasonic diathermy device, per month) are listed as not medically necessary / not covered for the indicated products.
Coding and billing
Provider actions, prior authorization, and billing guidance
Prior authorization not applicable
Prior authorization is not applicable for this policy.
No medical criteria or step therapy
No medical criteria or step therapy requirements are specified in this policy.
Verify member benefits and eligibility
Verify the member’s Evidence of Coverage or Subscriber Agreement and confirm eligibility/benefits with the provider call center prior to billing, since benefits may vary by group/contract.
- Check member-specific benefits and coverage limitations in the Evidence of Coverage or Subscriber Agreement.
- Contact the provider call center for confirmation of eligibility and benefits before submitting claims.
Background and clinical evidence
Therapeutic ultrasound, also called ultrasonic diathermy, uses high-frequency acoustic vibrations (≥20 kilohertz) to produce deep heat in collagen-rich tissues such as muscles, tendons, and ligaments. The generated vibrations increase tissue temperature and are believed to promote soft tissue repair and pain relief.
Conventional therapeutic ultrasound is clinic‑based with short treatment sessions (typically 5–10 minutes) using an applicator moved over the skin with coupling gel. Newer stationary or wearable devices provide continuous low‑intensity ultrasound for multihour home use; clinical studies (including a meta‑analysis and randomized controlled trials) have reported reductions in pain and improved outcomes with some sustained acoustic medicine devices, but overall evidence is heterogeneous and insufficient to demonstrate a clear net health benefit.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.